Cargando…

Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients

STUDY QUESTION: What is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria? SUMMARY ANSWER: The CDR of POSEIDON patients was on average ∼50% lower than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Sandro C, Yarali, Hakan, Vuong, Lan N, Carvalho, José F, Özbek, İrem Y, Polat, Mehtap, Le, Ho L, Pham, Toan D, Ho, Tuong M, Humaidan, Peter, Alviggi, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289325/ https://www.ncbi.nlm.nih.gov/pubmed/34179973 http://dx.doi.org/10.1093/humrep/deab152

Ejemplares similares

Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
por: Esteves, Sandro C., et al.
Publicado: (2021)

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
por: Esteves, Sandro C., et al.
Publicado: (2019)

Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF/ICSI cycles: a single-center retrospective study
por: Abdullah, Raed K., et al.
Publicado: (2020)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review
por: Mumusoglu, Sezcan, et al.
Publicado: (2021)

Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study
por: Yan, Enqi, et al.
Publicado: (2023)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Safety and effectiveness of acupuncture for POSEIDON patients in IVF/ICSI: A protocol for systematic review and meta-analysis
por: Zhu, Xinyun, et al.
Publicado: (2020)

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
por: Humaidan, Peter, et al.
Publicado: (2016)

Double or dual stimulation in poor ovarian responders: where do we stand?
por: Polat, Mehtap, et al.
Publicado: (2021)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
por: Esteves, Sandro C., et al.
Publicado: (2018)

Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles
por: Bansiwal, Reeta, et al.
Publicado: (2023)

The POSEIDON stratification - moving from poor ovarian response to low prognosis
por: Roque, Matheus, et al.
Publicado: (2021)

The true natural cycle frozen embryo transfer - impact of patient and follicular phase characteristics on serum progesterone levels one day prior to warmed blastocyst transfer
por: Mumusoglu, Sezcan, et al.
Publicado: (2023)

ESHRE guideline: ovarian stimulation for IVF/ICSI(†)
por: Bosch, Ernesto, et al.
Publicado: (2020)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
por: Khoa, Le Dang, et al.
Publicado: (2020)

Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI
por: Bosch, Ernesto, et al.
Publicado: (2020)

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
por: Esteves, Sandro C., et al.
Publicado: (2021)

IVF or ICSI for fertility preservation?
por: Aggarwal, Bhorika, et al.
Publicado: (2021)

Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Piette, Paul C M
Publicado: (2021)

Dyslipidemia Is Negatively Associated With the Cumulative Live-Birth Rate in Patients Without PCOS Following IVF/ICSI
por: Liu, Zhenteng, et al.
Publicado: (2021)

Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles
por: Mai, Zhuoyao, et al.
Publicado: (2021)

Can repeat IVF/ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ICSI cycles in Chinese advanced-aged population
por: Gu, Fang, et al.
Publicado: (2021)

Optimisation of the follicular phase in IVF/ICSI
por: Blockeel, C.
Publicado: (2012)

Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate
por: Zhong, Chenyi, et al.
Publicado: (2021)

Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Li, Yuan, et al.
Publicado: (2019)

Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Esteves, Sandro C., et al.
Publicado: (2020)

Correction: Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Prediction of ovarian response in IVF/ICSI cycles
por: Cortés-Vazquez, Alfredo, et al.
Publicado: (2021)

Comparison of clinical outcomes between in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in IVF-ICSI split insemination cycles
por: Lee, Sun Hee, et al.
Publicado: (2017)

GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis
por: Haahr, Thor, et al.
Publicado: (2017)

The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility
por: Wu, Yixuan, et al.
Publicado: (2021)

The Value of Automated Follicle Volume Measurements in IVF/ICSI
por: Vandekerckhove, Frank, et al.
Publicado: (2014)

Sperm DNA damage and its role in IVF and ICSI
por: Bach, Phil Vu, et al.
Publicado: (2016)

Smoking Decreases Endometrial Thickness in IVF/ICSI Patients
por: Heger, Anna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0dl9a0if1rff9ehk8b8do57j0v